1. Centers for Disease Control and Prevention, National Center for Health Statistics . Compressed mortality file 1999–2018 multiple cause of death 1999–2018 on CDC WONDER online database. 2020.
Google Scholar2. Centers for Disease Control and Prevention . Viral hepatitis surveillance—United States, 2017. 2019.
Google Scholar3. Hofmeister, MG, Rosenthal, EM, Barker, LK, et al. Estimating prevalence of hepatitis C virus infection in the United States, 2013–2016. Hepatology. 2019;69(3):1020-1031.
Google Scholar | Crossref | Medline4. Spearman, CW, Dusheiko, GM, Hellard, M, Sonderup, M. Hepatitis C. The Lancet. 2019;394(10207):1451-1466.
Google Scholar | Crossref | Medline5. Aspinall, EJ, Hutchinson, SJ, Janjua, NZ, et al. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment. J Hepatol. 2015;62(2):269-277.
Google Scholar | Crossref | Medline6. Grebely, J, Dore, GJ. What is killing people with hepatitis C virus infection? Paper presented at: seminars in liver disease. 2011.
Google Scholar | Crossref7. Mahajan, R, Xing, J, Liu, SJ, et al. Mortality among persons in care with hepatitis C virus infection: the chronic hepatitis cohort study (CHeCS), 2006–2010. Clin Infect Dis. 2014;58(8):1055-1061.
Google Scholar | Crossref | Medline8. United States Library of Medicine: Medscape . HCV Polymerase inhibitors. 2018; https://reference.medscape.com/drug/harvoni-ledipasvir-sofosbuvir-999970. Accessed May 13, 2019.
Google Scholar9. Li, J, Zhang, T, Gordon, SC, et al. Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States. J Viral Hepat. 2018;25(8):952-958.
Google Scholar | Crossref | Medline10. American Association for the Study of Liver Diseases: Infectious Diseases Society of America . HCV Guidance: recommendations for testing, managing, and treating hepatitis C. Overview of cost, reimbursement, and cost-effectiveness considerations for hepatitis C treatment regimens. 2017.
Google Scholar11. Goodman, S . Interview with Dr. Donna Tran, Kaiser Permanente Anaheim. In: Tran, DD , ed. 2019.
Google Scholar12. Zahn, M, Jacobs, J. Overview of hepatitis C in orange county. In: Goodman, S , ed.
Google Scholar13. World Health Organization . Global Hepatitis Report 2017. World Health Organization; 2017.
Google Scholar14. Applegate, TL, Fajardo, E, Sacks, JA. Hepatitis C virus diagnosis and the holy grail. Infect Dis Clin North Am. 2018;32(2):425-445.
Google Scholar | Crossref | Medline15. Skipper, C, Guy, J, Parkes, J, Roderick, P, Rosenberg, W. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy. Gut. 2003;52(10):1500-1504.
Google Scholar | Crossref | Medline16. Swellam, M, Mahmoud, MS, Ali, AAF. Diagnosis of hepatitis C virus infection by enzyme-linked immunosorbent assay and reverse transcriptase-nested polymerase chain reaction: a comparative evaluation. IUBMB life. 2011;63(6):430-434.
Google Scholar | Crossref | Medline17. Martin, NK, Vickerman, P, Dore, GJ, et al. Prioritization of HCV treatment in the direct-acting antiviral era: an economic evaluation. J Hepatol. 2016;65(1):17-25.
Google Scholar | Crossref | Medline18. Simmons, B, Saleem, J, Hill, A, Riley, RD, Cooke, GS. Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(6):683-694.
Google Scholar | Crossref | Medline19. Centers for Disease Control and Prevention . Viral hepatitis surveillance—United States, 2018. 2020.
Google Scholar20. Eckman, MH, Ward, JW, Sherman, KE. Cost effectiveness of universal screening for hepatitis C virus infection in the era of direct-acting, pangenotypic treatment regimens. Clinical Gastroenterology and Hepatology. 2019;17(5):930-939. e939.
Google Scholar | Crossref | Medline21. Chhatwal, J, He, T, Hur, C, Lopez-Olivo, MA. Direct-acting antiviral agents for patients with hepatitis C virus genotype 1 infection are cost-saving. Clin Gastroenterol Hepatol. 2017;15(6):827-837. e828.
Google Scholar | Crossref | Medline22. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America . HCV Guidance” recommendations for testing, managing, and treating hepatitis C. 2018.
Google Scholar23. Foster, GR, Irving, WL, Cheung, MC, et al. Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis. J Hepatol. 2016;64(6):1224-1231.
Google Scholar | Crossref | Medline24. Woolston, SL, Kim, HN. Cost and access to direct-acting antiviral agents. Evalu Prepar Hepatitis C Treatment 2017; https://www.hepatitisc.uw.edu/go/evaluation-treatment/cost-access-medications/core-concept/all#citations.
Google Scholar25. American Association for the Study of Liver Diseases: Infectious Diseases Society of America . HCV Guidance” recommendations for testing, managing, and treating hepatitis C. 2018.
Google Scholar26. Martin, NK, Vickerman, P, Dore, G, Hickman, M. The HCV epidemics in key populations (including PWID, prisoners, and MSM): the use of DAAs as treatment for prevention. Curr Opin HIV AIDS. 2015;10(5):374.
Google Scholar | Crossref | Medline27. Food and Drug Administration . Hepatitis B and C treatments. 2017.
Google Scholar28. Bruen, B, Brantley, E, Thompson, V, Steinmetz, E, Helmchen, L. High-Cost HCV Drugs in Medicaid: Final Report: Report for Medicaid and CHIP Payment and Access Commission (MACPAC), Contract # MACP16406T2. The George Washington University: Milliken Institute of Public Health;2017.
Google Scholar29. Andrews, M . Hepatitis C drug’s lower cost paves way for medicaid, prisons to expand treatment. Kaiser Health News. 2017.
Google Scholar30. Bor, J, Cohen, GH, Galea, S. Population health in an era of rising income inequality: USA, 1980–2015. The Lancet. 2017;389(10077):1475-1490.
Google Scholar | Crossref | Medline31. United States Census Bureau . Quick facts: Orange County, California orange county California. Washington, DC 2018.
Google Scholar32. Orange County Health Care Agency Epidemiology and Assessment Branch . Hepatitis C chronic cases In: California reportable disease information exchange. 2017.
Google Scholar33. McHugh, M, Wu, A, Chevaliez, S, Pawlotsky, J, Hallin, M, Templeton, K. Multicenter evaluation of the cepheid Xpert hepatitis C virus viral load assay. J Clin Microbiol. 2017;55(5):1550-1556.
Google Scholar | Crossref | Medline34. Wlassow, M, Poiteau, L, Roudot-Thoraval, F, et al. The new Xpert HCV viral load real-time PCR assay accurately quantifies hepatitis C virus RNA in serum and whole-blood specimens. J Clin Virol. 2019;117:80-84.
Google Scholar | Crossref | Medline35. Aibibula, W, Cox, J, Hamelin, AM, et al. Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people. HIV Med. 2018;19(2):123-131.
Google Scholar | Crossref | Medline36. Bregenzer, A, Warmann, N, Ottiger, C, Fux, CA. Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection. Swiss Med Wkly. 2019;149(4142).
Google Scholar37. Mücke, MM, Maasoumy, B, Dietz, J, et al. Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy. PloS one. 2019;14(11):e0224751.
Google Scholar | Crossref | Medline38. StataCorp . Stata 13 base reference manual. College Station, TX. 2013.
Google Scholar39. California Department of Public Health: Sexually Transmitted Diseases (STD) Control Branch: Office of Viral Hepatitis Prevention . Orange county – chronic hepatitis C cases and rates of newly reported cases, 2011–2015. 2017.
Google Scholar40. Association of Public Health Laboratories . Interpretation of hepatitis C virus test results: guidance for laboratories. Silver Spring, MD. 2019.
Google Scholar41. Cox, DR . Regression models and life-tables. J R Statist Soc B (Methodological). 1972;34(2):187-202.
Google Scholar | Crossref42. United States Census Bureau . Glossary: american community survey (ACS) health insurance definitions. 2016; https://www.census.gov/topics/health/health-insurance/about/glossary.html#par_textimage_18. Accessed April 10, 2020.
Google Scholar43. Freeman, VL, Ricardo, AC, Campbell, RT, Barrett, RE, Warnecke, RB. Association of census tract-level socioeconomic status with disparities in prostate cancer–specific survival. Cancer Epidemiol Prevent Biomarkers. 2011;20(10):2150-2159.
Google Scholar | Crossref | Medline44. United States Preventive Services Task Force . Hepatitis C: screening. Rockville, MD. 2013.
Google Scholar45. Galbraith, JW, Anderson, ES, Hsieh, Y. High prevalence of hepatitis C infection Among adult patients at four urban emergency departments — Birmingham, Oakland, Baltimore, and Boston, 2015–2017. Morb Mortal Wkly Rep. 2020(69):569-574.
Google Scholar | Crossref | Medline46. Ditah, I, Al Bawardy, B, Gonzalez, HC, et al. Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the national health and nutrition examination hepatitis C follow-up study. Am J Gastroenterol. 2015;110(8):1126-1133.
Google Scholar | Crossref | Medline47. Christy, SM, Reich, RR, Rathwell, JA, et al. Using the Electronic Health Record to Characterize the Hepatitis C Virus Care Cascade. Public Health Reports. April 2021: doi:10.1177/00333549211005812.
Google Scholar | SAGE Journals48. Vu, TM, Toribio, W, Riazi, F, et al. Increasing access to hepatitis C virus medications: a program model using patient navigators and specialty pharmacy to obtain prior authorization approval. J Manag Care Spec Pharm. 2018;24(4):329-333.
Google Scholar | Medline49. Sforza, T, Saavedra, T, Schwebke, S, Basheda, L, Schauer, M, Gritchen, J, et al. How some Southern California drug rehab centers exploit addiction [Internet]. Orange County Register. Orange County Register; 2018 [cited 2020 Feb 21]. Available from: https://www.ocregister.com/2017/05/21/how-some-southern-california-drug-rehab-centers-exploit-addiction/.
Google Scholar50. U.S. Preventive Services Task Force . Final recommendation statement: hepatitis C virus infection in adolescents and adults: screening. Rockville, MD. 2020.
Google Scholar